Omass (AgeTech UK) Biomed
High-res Mass Spec drug discovery: G-protein receptor, immuno-dysregulation, protein-protein interactions.
Technology:
AgeTech Companies
Industry:
UK AgeTech 2020
Headquarters:
United Kingdom
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership